Evidence map›Paper›PMID 36514342›Full record

ArticleNew microbes and new infections2023

Frequency, subtypes distribution, and risk factors of

Ali Taghipour, Majid Pirestani, Ramin Hamidi Farahani, Mohammad Barati, Esfandiar Asadipoor

Open access · goldAbstract read
In one paragraph

Article in New microbes and new infections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Prevalence ofNew microbes and new infections · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ali TaghipourInfectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran.
Majid PirestaniDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Ramin Hamidi FarahaniInfectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran.
Mohammad BaratiInfectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran.
Esfandiar AsadipoorInfectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran.
Aja University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recent theories on the possible interactions between the intestinal parasites and COVID-19 have stated that these co-infections may cause immune imbalance and further complications in the affected patients. Until now, there is no data about Method: Stool samples were gathered from 200 COVID-19 patients and 200 control, being matched regarding age, gender and residence. Then, stool samples were surveyed by parasitological methods, including direct slide smear and formalin-ether concentration. In the following, PCR and sequencing were used to detect Results: The frequency of Conclusions: Based on this results, health education, improved sanitation and good personal hygiene are highly recommended to prevent

Indexed as

BlastocystisCOVID-19IranSubtyping

Identifiers

PMID36514342
PMCPMC9733120
OpenAlexW4313424617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.